These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24963662)

  • 1. Plasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteers.
    Arévalo-Herrera M; Forero-Peña DA; Rubiano K; Gómez-Hincapie J; Martínez NL; Lopez-Perez M; Castellanos A; Céspedes N; Palacios R; Oñate JM; Herrera S
    PLoS One; 2014; 9(6):e99754. PubMed ID: 24963662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription Profiling of Malaria-Naïve and Semi-immune Colombian Volunteers in a Plasmodium vivax Sporozoite Challenge.
    Rojas-Peña ML; Vallejo A; Herrera S; Gibson G; Arévalo-Herrera M
    PLoS Negl Trop Dis; 2015; 9(8):e0003978. PubMed ID: 26244760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent safety and infectivity in sporozoite challenge model of Plasmodium vivax in malaria-naive human volunteers.
    Herrera S; Solarte Y; Jordán-Villegas A; Echavarría JF; Rocha L; Palacios R; Ramírez O; Vélez JD; Epstein JE; Richie TL; Arévalo-Herrera M
    Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):4-11. PubMed ID: 21292872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.
    Arévalo-Herrera M; Vásquez-Jiménez JM; Lopez-Perez M; Vallejo AF; Amado-Garavito AB; Céspedes N; Castellanos A; Molina K; Trejos J; Oñate J; Epstein JE; Richie TL; Herrera S
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005070. PubMed ID: 27760143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Profiling in Naïve and Semi-immune Individuals Experimentally Challenged with Plasmodium vivax Sporozoites.
    Arévalo-Herrera M; Lopez-Perez M; Dotsey E; Jain A; Rubiano K; Felgner PL; Davies DH; Herrera S
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004563. PubMed ID: 27014875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors.
    Herrera S; Fernández O; Manzano MR; Murrain B; Vergara J; Blanco P; Palacios R; Vélez JD; Epstein JE; Chen-Mok M; Reed ZH; Arévalo-Herrera M
    Am J Trop Med Hyg; 2009 Nov; 81(5):740-6. PubMed ID: 19861603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax sporozoite production in Anopheles albimanus mosquitoes for vaccine clinical trials.
    Solarte Y; Manzano MR; Rocha L; Hurtado H; James MA; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):28-34. PubMed ID: 21292875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Anopheles sinensis to Plasmodium vivax in malarial outbreak areas of central China.
    Zhu G; Xia H; Zhou H; Li J; Lu F; Liu Y; Cao J; Gao Q; Sattabongkot J
    Parasit Vectors; 2013 Jun; 6():176. PubMed ID: 23768077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge.
    Talley AK; Healy SA; Finney OC; Murphy SC; Kublin J; Salas CJ; Lundebjerg S; Gilbert P; Van Voorhis WC; Whisler J; Wang R; Ockenhouse CF; Heppner DG; Kappe SH; Duffy PE
    PLoS One; 2014; 9(11):e109654. PubMed ID: 25405724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
    Bennett JW; Yadava A; Tosh D; Sattabongkot J; Komisar J; Ware LA; McCarthy WF; Cowden JJ; Regules J; Spring MD; Paolino K; Hartzell JD; Cummings JF; Richie TL; Lumsden J; Kamau E; Murphy J; Lee C; Parekh F; Birkett A; Cohen J; Ballou WR; Polhemus ME; Vanloubbeeck YF; Vekemans J; Ockenhouse CF
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004423. PubMed ID: 26919472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine.
    Arévalo-Herrera M; Gaitán X; Larmat-Delgado M; Caicedo MA; Herrera SM; Henao-Giraldo J; Castellanos A; Devaud JC; Pannatier A; Oñate J; Corradin G; Herrera S
    Nat Commun; 2022 Mar; 13(1):1603. PubMed ID: 35338131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial.
    Lyke KE; Laurens M; Adams M; Billingsley PF; Richman A; Loyevsky M; Chakravarty S; Plowe CV; Sim BK; Edelman R; Hoffman SL
    PLoS One; 2010 Oct; 5(10):e13490. PubMed ID: 21042404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Plasmodium vivax sporozoite production from Anopheles stephensi in South West India.
    Mohanty AK; de Souza C; Harjai D; Ghavanalkar P; Fernandes M; Almeida A; Walke J; Manoharan SK; Pereira L; Dash R; Mascarenhas A; Gomes E; Thita T; Chery L; Anvikar AR; Kumar A; Valecha N; Rathod PK; Patrapuvich R
    Malar J; 2021 May; 20(1):221. PubMed ID: 34006297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus.
    Hurtado S; Salas ML; Romero JF; Zapata JC; Ortiz H; Arevalo-Herrera M; Herrera S
    Ann Trop Med Parasitol; 1997 Jan; 91(1):49-60. PubMed ID: 9093429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvador II strain of Plasmodium vivax in Aotus monkeys and mosquitoes for transmission-blocking vaccine trials.
    Collins WE; Richardson BB; Morris CL; Sullivan JS; Galland GG
    Am J Trop Med Hyg; 1998 Jul; 59(1):29-34. PubMed ID: 9684622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.
    Laurens MB; Billingsley P; Richman A; Eappen AG; Adams M; Li T; Chakravarty S; Gunasekera A; Jacob CG; Sim BK; Edelman R; Plowe CV; Hoffman SL; Lyke KE
    PLoS One; 2013; 8(7):e68969. PubMed ID: 23874828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
    Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions.
    Collins KA; Wang CY; Adams M; Mitchell H; Robinson GJ; Rampton M; Elliott S; Odedra A; Khoury D; Ballard E; Shelper TB; Lucantoni L; Avery VM; Chalon S; Moehrle JJ; McCarthy JS
    J Clin Invest; 2020 Jun; 130(6):2920-2927. PubMed ID: 32045385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of sporogonic cycle of Plasmodium vivax in experimentally infected Anopheles albimanus mosquitoes.
    Salas ML; Romero JF; Solarte Y; Olano V; Herrera MA; Herrera S
    Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():115-9. PubMed ID: 7565121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosquito Infectivity and Parasitemia after Controlled Human Malaria Infection.
    Walk J; van Gemert GJ; Graumans W; Sauerwein RW; Bijker EM
    Am J Trop Med Hyg; 2018 Jun; 98(6):1705-1708. PubMed ID: 29714158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.